New COVID-19 pills could be a game changer

The Therapeutic Goods Administration (TGA) recently approved two new oral treatments in the fight against COVID-19 – Paxlovid and Lageverio. The clinical trials of the new antiviral pills show promising signs with a high level of protection against severe illness and fatality.

Daily host Oscar Byrne spoke to Dr Nial Wheate, Associate Professor of the Sydney Pharmacy School, to explore how the drugs work and the development process.

To find out more, head over to the TGA’s Consumer Medicines Information website.